Extreme evolutionary conservation of functionally important regions in H1N1 influenza proteome

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Warren, Samantha ^a   Wan, Xiu Feng ^b   Conant, Gavin ^c   Korkin, Dmitry ^a,c  

^a University of Missouri   (United States)

^b MISSISSIPPI STATE UNIVERSITY   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL EVOLUTION; INFLUENZA A VIRUS, H1N1 SUBTYPE; PHYLOGENY; VIRAL PROTEINS;

EID: 84894288236     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081027     Document Type: Article

References (95)

1. Stevens J, Corper AL, Basler CF, Taubenberger JK, Palese P et al. (2004) Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. Science 303: 1866-1870. doi:10.1126/science.1093373. PubMed: 14764887.
2. Noton SL, Medcalf E, Fisher D, Mullin AE, Elton D et al. (2007) Identification of the domains of the influenza A virus M1 matrix protein required for NP binding, oligomerization and incorporation into virions. J Gen Virol 88: 2280-2290. doi:10.1099/vir.0.82809-0. PubMed: 17622633.
3. Harris A, Forouhar F, Qiu S, Sha B, Luo M (2001) The crystal structure of the influenza matrix protein M1 at neutral pH: M1-M1 protein interfaces can rotate in the oligomeric structures of M1. Virology 289: 34-44. doi:10.1006/viro.2001.1119. PubMed: 11601915.
4. Phongphanphanee S, Rungrotmongkol T, Yoshida N, Hannongbua S, Hirata F (2010) Proton transport through the influenza A M2 channel: three-dimensional reference interaction site model study. J Am Chem Soc 132: 9782-9788. doi:10.1021/ja1027293. PubMed: 20578761.
5. Stouffer AL, Acharya R, Salom D, Levine AS, Di Costanzo L et al. (2008) Structural basis for the function and inhibition of an influenza virus proton channel. Nature 451: 596-599. doi:10.1038/nature06528. PubMed: 18235504.
6. Wang J, Qiu JX, Soto C, Degrado WF (2011) Structural and dynamic mechanisms for the function and inhibition of the M2 proton channel from influenza A virus. Curr Opin Struct Biol, 21: 68-80. PubMed: 21247754.
7. Kochendoerfer GG, Salom D, Lear JD, Wilk-Orescan R, Kent SB et al. (1999) Total chemical synthesis of the integral membrane protein influenza A virus M2: role of its C-terminal domain in tetramer assembly. Biochemistry 38: 11905-11913. doi:10.1021/bi990720m. PubMed: 10508393.
8. Biswas SK, Boutz PL, Nayak DP (1998) Influenza virus nucleoprotein interacts with influenza virus polymerase proteins. J Virol 72: 5493-5501. PubMed: 9621005.
9. Kobayashi M, Toyoda T, Adyshev DM, Azuma Y, Ishihama A (1994) Molecular dissection of influenza virus nucleoprotein: deletion mapping of the RNA binding domain. J Virol 68: 8433-8436. PubMed: 7966640.
10. Elton D, Medcalf E, Bishop K, Digard P (1999) Oligomerization of the influenza virus nucleoprotein: identification of positive and negative sequence elements. Virology 260: 190-200. doi:10.1006/viro.1999.9818. PubMed: 10405371.
11. Wang W, Riedel K, Lynch P, Chien CY, Montelione GT et al. (1999) RNA binding by the novel helical domain of the influenza virus NS1 protein requires its dimer structure and a small number of specific basic amino acids. RNA 5: 195-205. doi:10.1017/S1355838299981621. PubMed: 10024172.
12. Darapaneni V, Prabhaker VK, Kukol A (2009) Large-scale analysis of influenza A virus sequences reveals potential drug target sites of non-structural proteins. J Gen Virol 90: 2124-2133. doi:10.1099/vir.0.011270-0. PubMed: 19420157.
13. Akarsu H, Burmeister WP, Petosa C, Petit I, Müller CW et al. (2003) Crystal structure of the M1 protein-binding domain of the influenza A virus nuclear export protein (NEP/NS2). EMBO J 22: 4646-4655. doi:10.1093/emboj/ cdg449. PubMed: 12970177.
14. Boulo S, Akarsu H, Ruigrok RW, Baudin F (2007) Nuclear traffic of influenza virus proteins and ribonucleoprotein complexes. Virus Res 124: 12-21. doi:10.1016/j.virusres.2006.09.013. PubMed: 17081640.
15. Hemerka JN, Wang D, Weng Y, Lu W, Kaushik RS et al. (2009) Detection and characterization of influenza A virus PA-PB2 interaction through a bimolecular fluorescence complementation assay. J Virol 83: 3944-3955. doi:10.1128/JVI. 02300-08. PubMed: 19193801.
16. Zürcher T, de la Luna S, Sanz-Ezquerro JJ, Nieto A, Ortín J (1996) Mutational analysis of the influenza virus A/Victoria/3/75 PA protein: studies of interaction with PB1 protein and identification of a dominant negative mutant. J Gen Virol 77 (8): 1745-1749. doi:10.1099/0022-1317-77-8-1745. PubMed: 8760421.
17. Nelson MI, Holmes EC (2007) The evolution of epidemic influenza. Nat Rev Genet 8: 196-205. doi:10.1038/nrg2053. PubMed: 17262054.
18. Tsai KN, Chen GW (2011) Influenza genome diversity and evolution. Microbes Infect 13: 479-488. doi:10.1016/j.micinf.2011.01.013. PubMed: 21276870.
19. Guilligay D, Tarendeau F, Resa-Infante P, Coloma R, Crepin T et al. (2008) The structural basis for cap binding by influenza virus polymerase subunit PB2. Nat Struct Mol Biol 15: 500-506. doi:10.1038/nsmb.1421. PubMed: 18454157.
20. Rambaut A, Pybus OG, Nelson MI, Viboud C, Taubenberger JK et al. (2008) The genomic and epidemiological dynamics of human influenza A virus. Nature 453: 615-619. doi:10.1038/nature06945. PubMed: 18418375.
21. Khatchikian D, Orlich M, Rott R (1989) Increased viral pathogenicity after insertion of a 28S ribosomal RNA sequence into the haemagglutinin gene of an influenza virus. Nature 340: 156-157. doi:10.1038/340156a0. PubMed: 2544809.
22. Orlich M, Gottwald H, Rott R (1994) Nonhomologous recombination between the hemagglutinin gene and the nucleoprotein gene of an influenza virus. Virology 204: 462-465. doi:10.1006/viro.1994.1555. PubMed: 8091680.
23. Mitnaul LJ, Matrosovich MN, Castrucci MR, Tuzikov AB, Bovin NV et al. (2000) Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus. J Virol 74: 6015-6020. doi:10.1128/JVI.74.13.6015-6020.2000. PubMed: 10846083.
24. Suarez DL, Senne DA, Banks J, Brown IH, Essen SC et al. (2004) Recombination resulting in virulence shift in avian influenza outbreak, Chile. Emerg Infect Dis 10: 693-699. doi:10.3201/eid1004.030396. PubMed: 15200862.
25. Pasick J, Handel K, Robinson J, Copps J, Ridd D et al. (2005) Intersegmental recombination between the haemagglutinin and matrix genes was responsible for the emergence of a highly pathogenic H7N3 avian influenza virus in British Columbia. J Gen Virol 86: 727-731. doi:10.1099/vir.0.80478-0. PubMed: 15722533.
26. McCullers JA, Saito T, Iverson AR (2004) Multiple genotypes of influenza B virus circulated between 1979 and 2003. J Virol 78: 12817-12828. doi:10.1128/JVI.78.23.12817-12828.2004. PubMed: 15542634.
27. Li C, Yu K, Tian G, Yu D, Liu L et al. (2005) Evolution of H9N2 influenza viruses from domestic poultry in Mainland China. Virology 340: 70-83. doi:10.1016/j.virol.2005.06.025. PubMed: 16026813.
28. Brown IH, Harris PA, McCauley JW, Alexander DJ (1998) Multiple genetic reassortment of avian and human influenza A viruses in European pigs, resulting in the emergence of an H1N2 virus of novel genotype. J Gen Virol 79 (12): 2947-2955. PubMed: 9880008.
29. Matsuzaki Y, Mizuta K, Sugawara K, Tsuchiya E, Muraki Y et al. (2003) Frequent reassortment among influenza C viruses. J Virol 77: 871-881. doi:10.1128/JVI.77.2.871-881.2003. PubMed: 12502803.
30. Widjaja L, Krauss SL, Webby RJ, Xie T, Webster RG (2004) Matrix gene of influenza a viruses isolated from wild aquatic birds: ecology and emergence of influenza a viruses. J Virol 78: 8771-8779. doi: 10.1128/JVI.78.16.8771-8779. 2004. PubMed: 15280485.
31. Honda A, Mizumoto K, Ishihama A (1999) Two separate sequences of PB2 subunit constitute the RNA cap-binding site of influenza virus RNA polymerase. Genes Cells 4: 475-485. doi:10.1046/j.1365-2443.1999.00275.x. PubMed: 10526235.
32. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S et al. (2009) Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325: 197-201. doi:10.1126/science. 1176225. PubMed: 19465683.
33. Xu R, Ekiert DC, Krause JC, Hai R, Crowe JE Jr. et al. (2010) Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science 328: 357-360. doi:10.1126/science.1186430. PubMed: 20339031.
34. Morens DM, Taubenberger JK, Fauci AS (2009) The persistent legacy of the 1918 influenza virus. N Engl J Med 361: 225-229. doi:10.1056/NEJMp0904819. PubMed: 19564629.
35. Ferguson NM, Galvani AP, Bush RM (2003) Ecological and immunological determinants of influenza evolution. Nature 422: 428-433. doi:10.1038/ nature01509. PubMed: 12660783.
36. Krystal M, Elliott RM, Benz EW Jr., Young JF, Palese P (1982) Evolution of influenza A and B viruses: conservation of structural features in the hemagglutinin genes. Proc Natl Acad Sci U S A 79: 4800-4804. doi:10.1073/pnas.79.15.4800. PubMed: 6956892.
37. Gorman OT, Bean WJ, Kawaoka Y, Webster RG (1990) Evolution of the nucleoprotein gene of influenza A virus. J Virol 64: 1487-1497. PubMed: 2319644.
38. Noble S, McGregor MS, Wentworth DE, Hinshaw VS (1993) Antigenic and genetic conservation of the haemagglutinin in H1N1 swine influenza viruses. J Gen Virol 74 (6): 1197-1200. doi:10.1099/0022-1317-74-6-1197. PubMed: 8389804.
39. Heiny AT, Miotto O, Srinivasan KN, Khan AM, Zhang GL et al. (2007) Evolutionarily conserved protein sequences of influenza a viruses, avian and human, as vaccine targets. PLOS ONE 2: e1190. doi:10.1371/journal.pone.0001190. PubMed: 18030326.
40. Dreyfus C, Laursen NS, Kwaks T, Zuijdgeest D, Khayat R et al. (2012) Highly conserved protective epitopes on influenza B viruses. Science 337: 1343-1348. doi:10.1126/science.1222908. PubMed: 22878502.
41. Ekiert DC, Kashyap AK, Steel J, Rubrum A, Bhabha G et al. (2012) Cross-neutralization of influenza A viruses mediated by a single antibody loop. Nature 489: 526-532. doi:10.1038/nature11414. PubMed: 22982990.
42. Caton AJ, Brownlee GG, Yewdell JW, Gerhard W (1982) The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31: 417-427. doi:10.1016/0092-8674(82)90135-0. PubMed: 6186384.
43. Biswas SK, Nayak DP (1996) Influenza virus polymerase basic protein 1 interacts with influenza virus polymerase basic protein 2 at multiple sites. J Virol 70: 6716-6722. PubMed: 8794308.
44. Shapira SD, Gat-Viks I, Shum BO, Dricot A, de Grace MM et al. (2009) A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 139: 1255-1267. doi:10.1016/j.cell.2009.12.018. PubMed: 20064372.
45. Guindon S, Gascuel O (2003) A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 52: 696-704. doi:10.1080/10635150390235520. PubMed: 14530136.
46. Nelson MI, Viboud C, Simonsen L, Bennett RT, Griesemer SB et al. (2008) Multiple reassortment events in the evolutionary history of H1N1 influenza A virus since 1918. PLoS Pathog 4: e1000012. PubMed: 18463694.
47. Zinder D, Bedford T, Gupta S, Pascual M (2013) The roles of competition and mutation in shaping antigenic and genetic diversity in influenza. PLoS Pathog 9: e1003104. PubMed: 23300455.
48. Greenbaum JA, Kotturi MF, Kim Y, Oseroff C, Vaughan K et al. (2009) Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci U S A 106: 20365-20370. doi:10.1073/pnas.0911580106. PubMed: 19918065.
49. Igarashi M, Ito K, Yoshida R, Tomabechi D, Kida H et al. (2010) Predicting the antigenic structure of the pandemic (H1N1) 2009 influenza virus hemagglutinin. PLOS ONE 5: e8553. doi:10.1371/journal.pone.0008553. PubMed: 20049332.
50. Wang Y-T, Chan C-h, Su Z-Y, Chen C-L (2010) Homology modeling, docking, and molecular dynamics reveal HR1039 as a potent inhibitor of 2009 A (H1N1) influenza neuraminidase. Biophys Chem 147: 74-80. doi:10.1016/j.bpc.2009.12.002. PubMed: 20045243.
51. Abdussamad J, Aris-Brosou Sp (2011) The nonadaptive nature of the H1N1 2009 Swine Flu pandemic contrasts with the adaptive facilitation of transmission to a new host. BMC evolutionary biology 11: 6
52. Tharakaraman K, Raman R, Stebbins NW, Viswanathan K, Sasisekharan V et al. (2013) Antigenically intact hemagglutinin in circulating avian and swine influenza viruses and potential for H3N2 pandemic. Sci Rep 3: 1822-. PubMed: 23661027.
53. Kuang X, Han JG, Zhao N, Pang B, Shyu CR et al. (2012) DOMMINO: a database of macromolecular interactions. Nucleic Acids Res 40: D501-D506. doi:10.1093/nar/gkr1128. PubMed: 22135305.
54. Ghedin E, Laplante J, DePasse J, Wentworth DE, Santos RP et al. (2011) Deep sequencing reveals mixed infection with 2009 pandemic influenza A (H1N1) virus strains and the emergence of oseltamivir resistance. J Infect Dis 203: 168-174. doi:10.1093/infdis/jiq040. PubMed: 21288815.
55. Guharoy M, Chakrabarti P (2010) Conserved residue clusters at protein-protein interfaces and their use in binding site identification. BMC Bioinformatics 11: 286. doi:10.1186/1471-2105-11-286. PubMed: 20507585.
56. Panjkovich A, Daura X (2010) Assessing the structural conservation of protein pockets to study functional and allosteric sites: implications for drug discovery. BMC Struct Biol 10: 9. doi:10.1186/1472-6807-10-9. PubMed: 20356358.
57. Ma B, Elkayam T, Wolfson H, Nussinov R (2003) Protein-protein interactions: structurally conserved residues distinguish between binding sites and exposed protein surfaces. Proc Natl Acad Sci U S A 100: 5772-5777. doi:10.1073/pnas.1030237100. PubMed: 12730379.
58. Swapna LS, Bhaskara RM, Sharma J, Srinivasan N (2012) Roles of residues in the interface of transient protein-protein complexes before complexation. Sci Rep 2: 334. PubMed: 22451863.
59. Wei CJ, Boyington JC, Dai K, Houser KV, Pearce MB et al. (2010) Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design. Sci Transl Med 2: 24ra21. PubMed: 20375007.
60. Woolhouse ME, Webster JP, Domingo E, Charlesworth B, Levin BR (2002) Biological and biomedical implications of the co-evolution of pathogens and their hosts. Nat Genet 32: 569-577. doi:10.1038/ng1202-569. PubMed: 12457190.
61. Gaydos JC, Hodder RA, Top FH, Soden VJ, Allen RG, et al. (1977) Swine Inftuenza A at Fort Dix, New Jersey (January,ÄìFebruary 1976). I. Case Finding and Clinical Study of Cases. Journal of Infectious Diseases 136: S356-S362
62. Neumann G, Noda T, Kawaoka Y (2009) Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459: 931-939. doi:10.1038/nature08157. PubMed: 19525932.
63. Smith GJ, Vijaykrishna D, Bahl J, Lycett SJ, Worobey M et al. (2009) Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459: 1122-1125. doi:10.1038/nature08182. PubMed: 19516283.
64. Fedson DS, Kessler HA (1983) A hospital-based influenza immunization program, 1977-78. Am J Public Health 73: 442-445. doi:10.2105/AJPH.73.4.442. PubMed: 6829828.
65. Sencer DJ, Millar JD (2006) Reflections on the 1976 swine flu vaccination program. Emerg Infect Dis 12: 29-33. PubMed: 16494713.
66. Pensaert M, Ottis K, Vandeputte J, Kaplan MM, Bachmann PA (1981) Evidence for the natural transmission of influenza A virus from wild ducts to swine and its potential importance for man. Bull World Health Organ 59: 75-78. PubMed: 6973418.
67. Schultz U, Fitch WM, Ludwig S, Mandler J, Scholtissek C (1991) Evolution of pig influenza viruses. Virology 183: 61-73. doi:10.1016/0042-6822(91)90118-U. PubMed: 2053297.
68. Guan Y, Shortridge KF, Krauss S, Li PH, Kawaoka Y et al. (1996) Emergence of avian H1N1 influenza viruses in pigs in China. J Virol 70: 8041-8046. PubMed: 8892928.
69. Bachmann PA, editor (1989) Swine influenza virus. Amsterdam, Netherlands: Elsevier. pp. 193-207.
70. Brown IH (2000) The epidemiology and evolution of influenza viruses in pigs. Vet Microbiol 74: 29-46. doi:10.1016/S0378-1135(00)00164-4. PubMed: 10799776.
71. Brown EG (2000) Influenza virus genetics. Biomed Pharmacother 54: 196-209. doi:10.1016/S0753-3322(00)89026-5. PubMed: 10872718.
72. Yin C, Khan JA, Swapna GV, Ertekin A, Krug RM et al. (2007) Conserved surface features form the double-stranded RNA binding site of non-structural protein 1 (NS1) from influenza A and B viruses. J Biol Chem 282: 20584-20592. doi:10.1074/jbc.M611619200. PubMed: 17475623.
73. Okuno Y, Isegawa Y, Sasao F, Ueda S (1993) A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains. J Virol 67: 2552-2558. PubMed: 7682624.
74. Fraser HB, Hirsh AE, Steinmetz LM, Scharfe C, Feldman MW (2002) Evolutionary rate in the protein interaction network. Science 296: 750-752. doi:10.1126/science.1068696. PubMed: 11976460.
75. Korber BT, Farber RM, Wolpert DH, Lapedes AS (1993) Covariation of mutations in the V3 loop of human immunodeficiency virus type 1 envelope protein: an information theoretic analysis. Proc Natl Acad Sci U S A 90: 7176-7180. doi:10.1073/pnas.90.15.7176. PubMed: 8346232.
76. Travers SA, Tully DC, McCormack GP, Fares MA (2007) A study of the coevolutionary patterns operating within the env gene of the HIV-1 group M subtypes. Mol Biol Evol 24: 2787-2801. doi:10.1093/molbev/msm213. PubMed: 17921487.
77. Corti D, Voss J, Gamblin SJ, Codoni G, Macagno A et al. (2011) A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333: 850-856. doi:10.1126/science. 1205669. PubMed: 21798894.
78. Ekiert DC, Friesen RH, Bhabha G, Kwaks T, Jongeneelen M et al. (2011) A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 333: 843-850. doi:10.1126/science.1204839. PubMed: 21737702.
79. Ekiert DC, Bhabha G, Elsliger MA, Friesen RH, Jongeneelen M et al. (2009) Antibody recognition of a highly conserved influenza virus epitope. Science 324: 246-251. doi:10.1126/science.1171491. PubMed: 19251591.
80. Sui J, Hwang WC, Perez S, Wei G, Aird D et al. (2009) Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol 16: 265-273. doi:10.1038/nsmb.1566. PubMed: 19234466.
81. Throsby M, van den Brink E, Jongeneelen M, Poon LL, Alard P et al. (2008) Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLOS ONE 3: e3942. doi:10.1371/journal.pone.0003942. PubMed: 19079604.
82. Pielak RM, Schnell JR, Chou JJ (2009) Mechanism of drug inhibition and drug resistance of influenza A M2 channel. Proc Natl Acad Sci U S A 106: 7379-7384. doi:10.1073/pnas.0902548106. PubMed: 19383794.
83. Gubareva LV (2004) Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors. Virus Res 103: 199-203. doi:10.1016/j.virusres.2004. 02.034. PubMed: 15163510.
84. Chen GL, Subbarao K (2009) Attacking the flu: neutralizing antibodies may lead to 'universal'. Vaccine - Nature Medicine 15: 1251-1252. doi:10.1038/nm1109-1251.
85. Blok V, Cianci C, Tibbles KW, Inglis SC, Krystal M et al. (1996) Inhibition of the influenza virus RNA-dependent RNA polymerase by antisera directed against the carboxy-terminal region of the PB2 subunit. J Gen Virol 77 (5): 1025-1033. doi: 10.1099/0022-1317-77-5-1025. PubMed: 8609468.
86. Katoh K, Misawa K, Kuma K, Miyata T (2002) MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic Acids Res 30: 3059-3066. doi:10.1093/nar/gkf436. PubMed: 12136088.
87. Sali A, Blundell TL (1993) Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234: 779-815. doi:10.1006/jmbi.1993.1626. PubMed: 8254673.
88. Koradi R, Billeter M, Wüthrich K (1996) MOLMOL: a program for display and analysis of macromolecular structures. J Mol Graph 14: 29-55. 8744573.
89. Valkenburg SA, Gras S, Guillonneau C, La Gruta NL, Thomas PG et al. (2010) Protective efficacy of cross-reactive CD8+ T cells recognising mutant viral epitopes depends on peptide-MHC-I structural interactions and T cell activation threshold. PLoS Pathog 6: e1001039. PubMed: 20711359.
90. Pond SL, Frost SD, Muse SV (2005) HyPhy: hypothesis testing using phylogenies. Bioinformatics 21: 676-679. doi:10.1093/bioinformatics/bti079. PubMed: 15509596.
91. Yang Z (1993) Maximum-likelihood estimation of phylogeny from DNA sequences when substitution rates differ over sites. Mol Biol Evol 10: 1396-1401. PubMed: 8277861.
92. Conant GC, Stadler PF (2009) Solvent exposure imparts similar selective pressures across a range of yeast proteins. Mol Biol Evol 26: 1155-1161. doi:10.1093/molbev/msp031. PubMed: 19233963.
93. Conant GC (2009) Neutral evolution on mammalian protein surfaces. Trends Genet 25: 377-381. doi:10.1016/j.tig.2009.07.004. PubMed: 19716195.
94. Sokal R, Rohlf F (1995) Biometry. WH Freeman. New York. p. 887.
95. Eswar N, Webb B, Marti-Renom MA, Madhusudhan MS, Eramian D, et al. (2006) Comparative protein structure modeling using Modeller. Current protocols in bioinformatics / editoral board, Andreas D Baxevanis [et al] Chapter 5: Unit 5 6